Marekani - Kiingereza - NLM (National Library of Medicine)

aphena pharma solutions - tennessee, llc - minoxidil (unii: 5965120sh1) (minoxidil - unii:5965120sh1) - minoxidil 2.5 mg - because of the potential for serious adverse effects, minoxidil tablets are indicated only in the treatment of hypertension that is symptomatic or associated with target organ damage and is not manageable with maximum therapeutic doses of a diuretic plus two other antihypertensive drugs. at the present time use in milder degrees of hypertension is not recommended because the benefit-risk relationship in such patients has not been defined. minoxidil reduced supine diastolic blood pressure by 20 mm hg or to 90 mm hg or less in approximately 75% of patients, most of who had hypertension that could not be controlled by other drugs. minoxidil tablets are contraindicated in pheochromocytoma, because it may stimulate secretion of catecholamines from the tumor through its antihypertensive action. minoxidil tablets are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

Marekani - Kiingereza - NLM (National Library of Medicine)

physicians total care, inc. - minoxidil (unii: 5965120sh1) (minoxidil - unii:5965120sh1) - minoxidil 2.5 mg - because of the potential for serious adverse effects, minoxidil tablets are indicated only in the treatment of hypertension that is symptomatic or associated with target organ damage and is not manageable with maximum therapeutic doses of a diuretic plus two other antihypertensive drugs. at the present time use in milder degrees of hypertension is not recommended because the benefit-risk relationship in such patients has not been defined. minoxidil reduced supine diastolic blood pressure by 20 mm hg or to 90 mm hg or less in approximately 75% of patients, most of whom had hypertension that could not be controlled by other drugs. minoxidil tablets are contraindicated in pheochromocytoma, because it may stimulate secretion of catecholamines from the tumor through its antihypertensive action. minoxidil is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

Marekani - Kiingereza - NLM (National Library of Medicine)

avkare - minoxidil (unii: 5965120sh1) (minoxidil - unii:5965120sh1) - minoxidil 2.5 mg - because of the potential for serious adverse effects, minoxidil tablets are indicated only in the treatment of hypertension that is symptomatic or associated with target organ damage and is not manageable with maximum therapeutic doses of a diuretic plus two other antihypertensive drugs. at the present time use in milder degrees of hypertension is not recommended because the benefit-risk relationship in such patients has not been defined. minoxidil reduced supine diastolic blood pressure by 20 mm hg or to 90 mm hg or less in approximately 75% of patients, most of who had hypertension that could not be controlled by other drugs. minoxidil tablets are contraindicated in pheochromocytoma, because it may stimulate secretion of catecholamines from the tumor through its antihypertensive action. minoxidil tablets are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

Marekani - Kiingereza - NLM (National Library of Medicine)

sun pharmaceutical industries, inc. - minoxidil (unii: 5965120sh1) (minoxidil - unii:5965120sh1) - minoxidil 2.5 mg - because of the potential for serious adverse effects, minoxidil tablets are indicated only in the treatment of hypertension that is symptomatic or associated with target organ damage and is not manageable with maximum therapeutic doses of a diuretic plus two other antihypertensive drugs. at the present time use in milder degrees of hypertension is not recommended because the benefit-risk relationship in such patients has not been defined. minoxidil reduced supine diastolic blood pressure by 20 mm hg or to 90 mm hg or less in approximately 75% of patients, most of who had hypertension that could not be controlled by other drugs. minoxidil tablets are contraindicated in pheochromocytoma, because it may stimulate secretion of catecholamines from the tumor through its antihypertensive action. minoxidil tablets are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

Marekani - Kiingereza - NLM (National Library of Medicine)

doh central pharmacy - minoxidil (unii: 5965120sh1) (minoxidil - unii:5965120sh1) - minoxidil 2.5 mg - because of the potential for serious adverse effects, minoxidil tablets are indicated only in the treatment of hypertension that is symptomatic or associated with target organ damage and is not manageable with maximum therapeutic doses of a diuretic plus two other antihypertensive drugs. at the present time use in milder degrees of hypertension is not recommended because the benefit-risk relationship in such patients has not been defined. minoxidil reduced supine diastolic blood pressure by 20 mm hg or to 90 mm hg or less in approximately 75% of patients, most of who had hypertension that could not be controlled by other drugs. minoxidil tablets are contraindicated in pheochromocytoma, because it may stimulate secretion of catecholamines from the tumor through its antihypertensive action. minoxidil tablets are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

Marekani - Kiingereza - NLM (National Library of Medicine)

american health packaging - minoxidil (unii: 5965120sh1) (minoxidil - unii:5965120sh1) - minoxidil 2.5 mg - because of the potential for serious adverse effects, minoxidil tablets are indicated only in the treatment of hypertension that is symptomatic or associated with target organ damage and is not manageable with maximum therapeutic doses of a diuretic plus two other antihypertensive drugs. at the present time use in milder degrees of hypertension is not recommended because the benefit-risk relationship in such patients has not been defined. minoxidil reduced supine diastolic blood pressure by 20 mm hg or to 90 mm hg or less in approximately 75% of patients, most of who had hypertension that could not be controlled by other drugs. minoxidil tablets are contraindicated in pheochromocytoma, because it may stimulate secretion of catecholamines from the tumor through its antihypertensive action. minoxidil is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

Marekani - Kiingereza - NLM (National Library of Medicine)

par pharmaceutical, inc. - minoxidil (unii: 5965120sh1) (minoxidil - unii:5965120sh1) - minoxidil 10 mg - because of the potential for serious adverse effects, minoxidil tablets are indicated only in the treatment of hypertension that is symptomatic or associated with target organ damage and is not manageable with maximum therapeutic doses of a diuretic plus two other antihypertensive drugs. at the present time use in milder degrees of hypertension is not recommended because the benefit-risk relationship in such patients has not been defined. minoxidil reduced supine diastolic blood pressure by 20 mmhg or to 90 mmhg or less in approximately 75% of patients, most of who had hypertension that could not be controlled by other drugs. minoxidil tablets are contraindicated in pheochromocytoma, because it may stimulate secretion of catecholamines from the tumor through its antihypertensive action. minoxidil is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

Marekani - Kiingereza - NLM (National Library of Medicine)

actavis pharma, inc. - minoxidil (unii: 5965120sh1) (minoxidil - unii:5965120sh1) - minoxidil 2.5 mg - because of the potential for serious adverse effects, minoxidil tablets are indicated only in the treatment of hypertension that is symptomatic or associated with target organ damage and is not manageable with maximum therapeutic doses of a diuretic plus two other antihypertensive drugs. at the present time use in milder degrees of hypertension is not recommended because the benefit-risk relationship in such patients has not been defined. minoxidil reduced supine diastolic blood pressure by 20 mm hg or to 90 mm hg or less in approximately 75% of patients, most of who had hypertension that could not be controlled by other drugs. minoxidil tablets are contraindicated in pheochromocytoma, because it may stimulate secretion of catecholamines from the tumor through its antihypertensive action. minoxidil is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

Ayalandi - Kiingereza - HPRA (Health Products Regulatory Authority)

careforsons ireland limited - minoxidil - cutaneous solution - 5 percent weight/volume - minoxidil

Marekani - Kiingereza - NLM (National Library of Medicine)

state of florida doh central pharmacy - minoxidil (unii: 5965120sh1) (minoxidil - unii:5965120sh1) - minoxidil 10 mg - because of the potential for serious adverse effects, minoxidil tablets are indicated only in the treatment of hypertension that is symptomatic or associated with target organ damage and is not manageable with maximum therapeutic doses of diuretic plus two other antihypertensive drugs. at the present time use in milder degrees of hypertension is not recommended because the benefit-risk relationship in such patients has not been defined. minoxidil reduced supine diastolic blood pressure by 20 mmhg or to 90 mmhg or less in approximately 75% of patients, most of whom had hypertension that could not be controlled by other drugs. minoxidil tablets are contraindicated in pheochromocytoma, because it may stimulate secretion of catecholamines from the tumor through its antihypertensive action. minoxidil is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.